{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:59:10Z","timestamp":1781236750144,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04618-8","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:38:58Z","timestamp":1781235538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NTRK-rearranged uterine sarcomas with heterologous rhabdomyoblastic and cartilaginous differentiation: expanding the morphological spectrum with discussion of passenger NTRK molecular events"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-089X","authenticated-orcid":false,"given":"Allen W.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Razack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"De Wet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemurai","family":"Bikwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro P.","family":"Aldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"7","key":"4618_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","volume":"32","author":"S Croce","year":"2019","unstructured":"Croce S, Hostein I, Longacre TA et al (2019) Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol 32(7):1008\u20131022. https:\/\/doi.org\/10.1038\/s41379-018-0184-6","journal-title":"Mod Pathol"},{"issue":"6","key":"4618_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","volume":"42","author":"S Chiang","year":"2018","unstructured":"Chiang S, Cotzia P, Hyman Dea et al (2018) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42(6):791\u2013798. https:\/\/doi.org\/10.1097\/PAS.0000000000001055","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"4618_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/PAS.0000000000001929","volume":"46","author":"DC Costigan","year":"2022","unstructured":"Costigan DC, Nucci MR, Dickson Bea et al (2022) NTRK-rearranged uterine sarcomas: clinicopathologic features of 15 cases, literature review, and risk stratification. Am J Surg Pathol 46(10):1415\u20131429. https:\/\/doi.org\/10.1097\/PAS.0000000000001929","journal-title":"Am J Surg Pathol"},{"key":"4618_CR4","doi-asserted-by":"publisher","first-page":"PO.18.00183","DOI":"10.1200\/PO.18.00183","volume":"2018","author":"R Okamura","year":"2018","unstructured":"Okamura R, Boichard A, Kato S, Sicklick JK, Bazhenova L, Kurzrock R (2018) Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: implications for NTRK-targeted therapeutics. JCO Precis Oncol 2018:PO.18.00183. https:\/\/doi.org\/10.1200\/PO.18.00183","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"4618_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar Sea et al (2020) Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol 21(4):531\u2013540. https:\/\/doi.org\/10.1016\/S1470-2045(19)30856-3","journal-title":"Lancet Oncol"},{"issue":"8","key":"4618_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/PAS.0000000000001292","volume":"43","author":"M Michal","year":"2019","unstructured":"Michal M, H\u00e1jkov\u00e1 V, Sk\u00e1lov\u00e1 A, Michal M (2019) STRN-NTRK3-rearranged mesenchymal tumor of the uterus: expanding the morphologic spectrum of tumors with NTRK fusions. Am J Surg Pathol 43(8):1152\u20131154. https:\/\/doi.org\/10.1097\/PAS.0000000000001292","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4618_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41379-021-01005-3","volume":"35","author":"JW Tsai","year":"2022","unstructured":"Tsai JW, Lee JC, Hsieh Tea, Lee P-H et al (2022) Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Mod Pathol 35(7):911\u2013921. https:\/\/doi.org\/10.1038\/s41379-021-01005-3","journal-title":"Mod Pathol"},{"issue":"10","key":"4618_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0000000000000675","volume":"40","author":"NP Agaram","year":"2016","unstructured":"Agaram NP, Zhang L, Sung Yea et al (2016) Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors. Am J Surg Pathol 40(10):1407\u20131416. https:\/\/doi.org\/10.1097\/PAS.0000000000000675","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4618_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/his.15306","volume":"85","author":"C Thellman","year":"2024","unstructured":"Thellman C, Halling KC, Saglam O (2024) NTRK fusion cervical sarcoma with rhabdoid cells and misleading molecular testing. Histopathology 85(6):959\u2013961. https:\/\/doi.org\/10.1111\/his.15306","journal-title":"Histopathology"},{"issue":"5","key":"4618_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/PGP.0000000000001014","volume":"43","author":"R Razack","year":"2024","unstructured":"Razack R, Butt JL, Hostein Iea et al (2024) SMARCB1 (INI1) deficient tumours of the uterine cervix: report of two cases, including one associated with an NTRK fusion. Int J Gynecol Pathol 43(5):464\u2013471. https:\/\/doi.org\/10.1097\/PGP.0000000000001014","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"4618_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/PAS.0b013e318208f72e","volume":"35","author":"AM Mills","year":"2011","unstructured":"Mills AM, Karamchandani JR, Vogel H, Longacre TA (2011) Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma): report of a novel entity possibly related to endocervical CD34 fibrocytes. Am J Surg Pathol 35(3):404\u2013412. https:\/\/doi.org\/10.1097\/PAS.0b013e318208f72e","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4618_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/PAS.0000000000001644","volume":"45","author":"KA Devereaux","year":"2021","unstructured":"Devereaux KA, Weiel JJ, Mills AM, Kunder CA, Longacre TA (2021) Neurofibrosarcoma revisited: an institutional case series of uterine sarcomas harboring kinase-related fusions with report of a novel FGFR1-TACC1 fusion. Am J Surg Pathol 45(5):638\u2013652. https:\/\/doi.org\/10.1097\/PAS.0000000000001644","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4618_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","volume":"32","author":"Z Gatalica","year":"2019","unstructured":"Gatalica Z, Xiu J, Swensen J, Vranic S (2019) Molecular characterization of cancers with NTRK gene fusions. Mod Pathol 32(1):147\u2013153. https:\/\/doi.org\/10.1038\/s41379-018-0118-3","journal-title":"Mod Pathol"},{"issue":"3","key":"4618_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/his.15082","volume":"84","author":"MS Moura","year":"2024","unstructured":"Moura MS, Costa J, Velasco Vea et al (2024) Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. Histopathology 84(3):451\u2013462. https:\/\/doi.org\/10.1111\/his.15082","journal-title":"Histopathology"},{"issue":"2","key":"4618_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","volume":"34","author":"I Br\u010di\u0107","year":"2021","unstructured":"Br\u010di\u0107 I, Godschachner TM, Bergovec Mea et al (2021) Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions. Mod Pathol 34(2):396\u2013407. https:\/\/doi.org\/10.1038\/s41379-020-00657-x","journal-title":"Mod Pathol"},{"issue":"8","key":"4618_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.5858\/arpa.2020-0400-RA","volume":"145","author":"E Conde","year":"2021","unstructured":"Conde E, Hernandez S, Sanchez Eea et al (2021) Pan-TRK immunohistochemistry: an example-based practical approach to efficiently identify patients with NTRK fusion cancer. Arch Pathol Lab Med 145(8):1031\u20131040. https:\/\/doi.org\/10.5858\/arpa.2020-0400-RA","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"4618_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado Aea et al (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33(1):38\u201346. https:\/\/doi.org\/10.1038\/s41379-019-0324-7","journal-title":"Mod Pathol"},{"issue":"6","key":"4618_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/his.14292","volume":"78","author":"N Mohammad","year":"2021","unstructured":"Mohammad N, Stewart CJR, Chiang Sea et al (2021) p53 immunohistochemical analysis of fusion-positive uterine sarcomas. Histopathology 78(6):805\u2013813. https:\/\/doi.org\/10.1111\/his.14292","journal-title":"Histopathology"},{"issue":"4","key":"4618_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","volume":"40","author":"CN Prieto-Granada","year":"2016","unstructured":"Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR (2016) Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST. Am J Surg Pathol 40(4):479\u2013489. https:\/\/doi.org\/10.1097\/PAS.0000000000000564","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4618_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/modpathol.2016.45","volume":"29","author":"AHG Cleven","year":"2016","unstructured":"Cleven AHG, Sannaa GAA, Briaire-de Bruijn Iea et al (2016) Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(6):582\u2013590. https:\/\/doi.org\/10.1038\/modpathol.2016.45","journal-title":"Mod Pathol"},{"issue":"12","key":"4618_CR21","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/modpathol.2017.97","volume":"30","author":"M Pekmezci","year":"2017","unstructured":"Pekmezci M, Cuevas-Ocampo AK, Perry A, Horvai AE (2017) Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors. Mod Pathol 30(12):1710\u20131719. https:\/\/doi.org\/10.1038\/modpathol.2017.97","journal-title":"Mod Pathol"},{"issue":"1","key":"4618_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/modpathol.2015.134","volume":"29","author":"IM Schaefer","year":"2016","unstructured":"Schaefer IM, Fletcher CD, Hornick JL (2016) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29(1):4\u201313. https:\/\/doi.org\/10.1038\/modpathol.2015.134","journal-title":"Mod Pathol"},{"issue":"3","key":"4618_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.prp.2017.12.015","volume":"214","author":"H Otsuka","year":"2018","unstructured":"Otsuka H, Kohashi K, Yoshimoto Mea et al (2018) Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors. Pathol Res Pract 214(3):417\u2013425. https:\/\/doi.org\/10.1016\/j.prp.2017.12.015","journal-title":"Pathol Res Pract"},{"issue":"12","key":"4618_CR24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/modpathol.2017.91","volume":"30","author":"S Le Guellec","year":"2017","unstructured":"Le Guellec S, Macagno N, Velasco Vea et al (2017) Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions. Mod Pathol 30(12):1677\u20131687. https:\/\/doi.org\/10.1038\/modpathol.2017.91","journal-title":"Mod Pathol"},{"issue":"6","key":"4618_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/modpathol.2017.8","volume":"30","author":"KJ Busam","year":"2017","unstructured":"Busam KJ, Pulitzer MP, Coit Dea et al (2017) Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors. Mod Pathol 30(6):877\u2013883. https:\/\/doi.org\/10.1038\/modpathol.2017.8","journal-title":"Mod Pathol"},{"key":"4618_CR26","doi-asserted-by":"publisher","first-page":"151735","DOI":"10.1016\/j.anndiagpath.2021.151735","volume":"52","author":"T Tomassen","year":"2021","unstructured":"Tomassen T, Kester LA, Tops Bea et al (2021) Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: immunohistochemical and molecular analysis of 25 cases. Ann Diagn Pathol 52:151735. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151735","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"4618_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00428-017-2242-8","volume":"472","author":"T Mentzel","year":"2018","unstructured":"Mentzel T, Kiss K (2018) Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast. Virchows Arch 472(3):361\u2013368. https:\/\/doi.org\/10.1007\/s00428-017-2242-8","journal-title":"Virchows Arch"},{"issue":"3","key":"4618_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41379-018-0140-5","volume":"32","author":"N Makise","year":"2019","unstructured":"Makise N, Sekimizu M, Konishi Eea et al (2019) H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features. Mod Pathol 32(3):435\u2013445. https:\/\/doi.org\/10.1038\/s41379-018-0140-5","journal-title":"Mod Pathol"},{"issue":"1","key":"4618_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/his.14069","volume":"77","author":"JT Rabban","year":"2020","unstructured":"Rabban JT, Devine WP, Sangoi Aea et al (2020) NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma. Histopathology 77(1):100\u2013111. https:\/\/doi.org\/10.1111\/his.14069","journal-title":"Histopathology"},{"issue":"11","key":"4618_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/gcc.22767","volume":"58","author":"AJ Suurmeijer","year":"2019","unstructured":"Suurmeijer AJ, Dickson BC, Swanson Dea et al (2019) The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements. Genes Chromosomes Cancer 58(11):739\u2013746. https:\/\/doi.org\/10.1002\/gcc.22767","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"4618_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.pathol.2022.10.003","volume":"55","author":"L Yin","year":"2023","unstructured":"Yin L, Shi C, He Xea et al (2023) NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China. Pathology (Phila) 55(3):362\u2013374. https:\/\/doi.org\/10.1016\/j.pathol.2022.10.003","journal-title":"Pathology (Phila)"},{"issue":"1","key":"4618_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00401-022-02515-3","volume":"145","author":"LS Hiemcke-Jiwa","year":"2023","unstructured":"Hiemcke-Jiwa LS, Meister MT, Martin Eea et al (2023) NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target. Acta Neuropathol 145(1):149\u2013152. https:\/\/doi.org\/10.1007\/s00401-022-02515-3","journal-title":"Acta Neuropathol"},{"issue":"2","key":"4618_CR33","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.esmoop.2023.101202","volume":"8","author":"A Dufresne","year":"2023","unstructured":"Dufresne A, Pissaloux D, Ngo C et al (2023) Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors. ESMO Open 8(2):101202. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101202","journal-title":"ESMO Open"},{"issue":"11","key":"4618_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","volume":"41","author":"JF Hechtman","year":"2017","unstructured":"Hechtman JF, Benayed R, Hyman Dea et al (2017) Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol 41(11):1547\u20131551. https:\/\/doi.org\/10.1097\/PAS.0000000000000911","journal-title":"Am J Surg Pathol"},{"key":"4618_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejca.2022.06.030","volume":"173","author":"LM Hondelink","year":"2022","unstructured":"Hondelink LM, Schrader AMR, Asri Aghmuni Gea et al (2022) The sensitivity of pan-TRK immunohistochemistry in solid tumours: a meta-analysis. Eur J Cancer 173:229\u2013237. https:\/\/doi.org\/10.1016\/j.ejca.2022.06.030","journal-title":"Eur J Cancer"},{"issue":"5","key":"4618_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.pathol.2023.05.002","volume":"55","author":"MA Nguyen","year":"2023","unstructured":"Nguyen MA, Colebatch AJ, Van Beek D, Tierney G, Gupta R, Cooper WA (2023) NTRK fusions in solid tumours: what every pathologist needs to know. Pathology (Phila) 55(5):596\u2013609. https:\/\/doi.org\/10.1016\/j.pathol.2023.05.002","journal-title":"Pathology (Phila)"},{"key":"4618_CR37","doi-asserted-by":"publisher","first-page":"104891","DOI":"10.1016\/j.oraloncology.2020.104891","volume":"111","author":"D Wei","year":"2020","unstructured":"Wei D, Qi C, Wu Y, Zhang X, Ren G (2020) AKAP13-NTRK3: a novel NTRK3 oncogenic fusion variant in a patient with melanoma. Oral Oncol 111:104891. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104891","journal-title":"Oral Oncol"},{"key":"4618_CR38","doi-asserted-by":"publisher","unstructured":"Magall\u00f3n-Lorenz M, Fern\u00e1ndez-Rodr\u00edguez J, Mazuelas H et al (n.d.) Identification of malignant peripheral nerve sheath tumor subtypes with distinct genomic identities. bioRxiv. https:\/\/doi.org\/10.64898\/2026.03.31.715523 (Preprint posted online April 2, 2026:2026.03.31.715523)","DOI":"10.64898\/2026.03.31.715523"},{"issue":"1","key":"4618_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/gcc.23089","volume":"62","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi H, Makise N, Shinozaki-Ushiku Aea, Ushiku T et al (2023) Dramatic response to entrectinib in a patient with malignant peripheral nerve sheath tumor harboring novel SNRNP70-NTRK3 fusion gene. Genes Chromosomes Cancer 62(1):47\u201351. https:\/\/doi.org\/10.1002\/gcc.23089","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04618-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:39:03Z","timestamp":1781235543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04618-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":39,"alternative-id":["4618"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04618-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant competing interests to disclose. No funding, grants or other support was received.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}